# US 2026/0061131 A1 · Syringe for an eye operation, having a viscoelastic chamber and a decomposition reagent chamber > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2026/0061131 A1 - Document ID: US20260061131A1 - Status: Published application - Kind: A1 - Application number: 19/384,982 - Filed: 2025-11-10 - Published: 2026-03-05 - Earliest claimed: 2023-05-12 - Assignees: Carl Zeiss Meditec AG - Applicants: Carl Zeiss Meditec AG - Inventors: Michael Haisch; Ben Robertson - Web page: https://patentgrep.com/patent/US20260061131A1 ## CPC - A61M 5/19: having more than one chamber - A61F 9/0008: {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00)} - A61F 9/00736: {Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments (A61F9/008 takes precedence)} - A61M 5/2066: {comprising means for injection of two or more media, e.g. by mixing} - A61M 5/3134: {characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula} - A61M 5/31511: {Piston or piston-rod constructions, e.g. connection of piston with piston-rod (A61M5/5066 takes precedence)} - A61M 2210/0612: Eyes - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} - A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C) ## Abstract A syringe is for an eye operation. The syringe has a syringe body, a plunger arranged in the syringe body so as to be displaceable in the syringe longitudinal direction, a viscoelastic chamber in which a viscoelastic is arranged, and a decomposition reagent chamber which is arranged separately from the viscoelastic chamber and in which a decomposition reagent is arranged for decomposing the viscoelastic. The syringe has a storage state, in which the viscoelastic and the decomposition reagent are arranged separately from one another, and a use state, into which the syringe is able to be put by longitudinally displacing the plunger and in which the viscoelastic and the decomposition reagent are mixed with one another. ## Claims ### Claim 1 A syringe for an eye operation, the syringe comprising: a syringe body; a plunger arranged in said syringe body so as to be displaceable in a syringe longitudinal direction; a viscoelastic chamber in which a viscoelastic is arranged; a decomposition reagent chamber arranged separately from said viscoelastic chamber and in which a decomposition reagent configured to decompose the viscoelastic is arranged; and, wherein the syringe has a storage state, in which the viscoelastic and the decomposition reagent are arranged separately from each other, and a use state, into which the syringe can be brought by a longitudinal displacement of said plunger and in which the viscoelastic and the decomposition reagent are mixed with each other. ### Claim 2 (depends on 1) The syringe of claim 1, wherein at least one of: the viscoelastic includes at least one of hyaluronic acid and a salt of hyaluronic acid and the decomposition reagent includes hyaluronidase; and, the viscoelastic includes hydroxypropyl methylcellulose and the decomposition reagent includes a cellulase. ### Claim 3 (depends on 1) The syringe of claim 1 further comprising a cannula via which the viscoelastic and the decomposition reagent are displaceable out of the syringe by a longitudinal displacement of said plunger in the syringe longitudinal direction. ### Claim 4 (depends on 3) The syringe of claim 3, wherein said syringe body includes a partition wall; and, said viscoelastic chamber and said decomposition reagent chamber are arranged next to each other in a direction perpendicular to the syringe longitudinal direction and are separated from each other via said partition wall. ### Claim 5 (depends on 4) The syringe of claim 4 further comprising: a mixing chamber arranged such that the viscoelastic and the decomposition reagent enter said mixing chamber when said plunger is displaced in the syringe longitudinal direction. ### Claim 6 (depends on 5) The syringe of claim 5, wherein said mixing chamber is arranged such that the viscoelastic and the decomposition reagent together exit said mixing chamber and then pass into said cannula when said plunger is displaced in the syringe longitudinal direction. ### Claim 7 (depends on 5) The syringe of claim 5, wherein the syringe has a tip region and a body region; said tip region is configured to be detachably coupled with said body region; and, said mixing chamber is arranged in said tip region and said viscoelastic chamber and said decomposition reagent chamber are arranged in said body region. ### Claim 8 (depends on 4) The syringe of claim 4, wherein said plunger includes a first partial plunger configured to displace the viscoelastic out of said viscoelastic chamber and a second partial plunger arranged separately from said first partial plunger; and, said second partial plunger is configured to displace the decomposition reagent out of said decomposition reagent chamber. ### Claim 9 (depends on 8) The syringe of claim 8, wherein said second partial plunger has a predetermined breaking point. ### Claim 10 (depends on 3) The syringe of claim 3 further comprising: a stopper arranged in said syringe body so as to be displaceable in the syringe longitudinal direction and configured to be driven from outside said syringe body for this displacement; and, said decomposition reagent chamber and said viscoelastic chamber being arranged consecutively in the syringe longitudinal direction and being separated from each other via said stopper, which delimits a line via which the viscoelastic can flow from said viscoelastic chamber into said decomposition reagent chamber and the decomposition reagent can flow from said decomposition reagent chamber into said viscoelastic chamber. ### Claim 11 (depends on 10) The syringe of claim 10, wherein said stopper includes a valve configured to block said line in the storage state and to open said line when a pressure difference between said viscoelastic chamber and said decomposition reagent chamber is exceeded. ### Claim 12 (depends on 10) The syringe of claim 10, wherein said plunger is formed by an outer plunger and an inner plunger which is mounted longitudinally displaceably within said outer plunger; and, said stopper is either fastened to said outer plunger or to said inner plunger. ### Claim 13 (depends on 1) The syringe of claim 1, wherein the viscoelastic includes hydroxypropyl methylcellulose and the decomposition reagent includes at least one of an exoglucanase and an endoglucanase.